Nuclear scintigraphy is one of the less frequently used diagnostic imaging modalities in veterinary medicine because it uses radionuclides, which are expensive and heavily regulated. In addition, the images derived from the studies are physiological in nature and therefore quite unfamiliar to most veterinarians. However, nuclear scintigraphy provides information on pathological and physiological processes that cannot otherwise be obtained.
Diagnostic nuclear medicine imaging involves dosing the patient with a very small amount of a gamma rayâ€“emitting radioisotope. The location and distribution of the radioisotope within the body is then detected with a gamma camera, a device specifically designed to collimate and detect gamma rays. The isotope can be injected, ingested, or inhaled as appropriate for the study being performed.
The radioisotope is usually part of a larger molecule that has a specific affinity for the tissue or organ of interest. For instance, some organic phosphonates have an affinity for bone, and isotopes bound to sulfur colloids will localize in the liver and spleen.
Very few radioisotopes have direct affinity for a given tissue; iodine is the notable exception and localizes very strongly in the thyroid (see thyroid adenoma image). Inhaled gases or aerosols localize in the airways and lungs and might or might not be absorbed into the bloodstream. In veterinary medicine, the most commonly used isotope is metastable technetium Tc 99m, although radioactive iodine, indium, and thallium are also used in specific instances.
Courtesy of Dr. Jimmy Lattimer.
The data collected by the gamma camera can be displayed directly on a monitor and stored in a digital file as a permanent record. Most modern systems send the data to a computer system for analysis, which allows enhancement of count differences and determination of organ margins. The operator can select regions of interest to analyze for isotope content and rate of accumulation over time.
When the study uses a radiopharmaceutical that is metabolized or has a limited residence time in an organ, organ function can be determined. These dynamic studies can be used to evaluate the function of organs such as the lungs, kidneys, and heart. Such studies can reveal abnormalities that static forms of anatomical imaging cannot detect.
Functional imaging is the great strength of nuclear medicine and allows disease detection earlier and more readily than anatomical imaging systems. Advanced MRI studies can emulate this functional aspect of scintigraphic imaging in some cases; however, those systems are much more limited in scope and availability, as well as costing an order of magnitude more.
Single photon emission computed tomography (SPECT) and positron emission tomography (PET) are advanced scintigraphic imaging techniques widely used in human medicine for detection and evaluation of many diseases. In both of these techniques, a CT-like cross-sectional image based on the deposition of radionuclides within the body is generated. Such images have greater sensitivity than planar images and improved specificity as well.
PET imaging in particular has experienced tremendous growth and is routinely used in the staging and evaluation of many diseases, especially cancer and some neurodegenerative disorders in small animals. This technology, based on the use of positron-emitting isotopes of lighter elements such as oxygen, nitrogen, carbon, and fluorine that can be inserted into compounds normally metabolized by the body, can evaluate the metabolism and localization of these elements with great sensitivity. Because of the unique properties of positrons, the location at which these particles are deposited in the body can be determined within millimeters, even in very large patients.
PET imaging is available at some academic centers, and its use exceeds that of traditional nuclear scintigraphy in some centers. These instruments are extremely sensitive and can often define the presence of or characterize the extent of some disease processes long before they can be evaluated by anatomical imaging systems such as MRI or CT. When these images are combined, or coregistered, with CT or MRI images, tremendous sensitivity for the detection of numerous diseases results.
PET/CT and PET/MRI scanners are hybrid imaging systems that combine the anatomical sensitivity of CT and MRI with the physiological sensitivity of PET to provide localization of foci of disease that could easily be missed using either instrument alone. These hybrid images are now considered standard of care in the management of many cancerous and metabolic diseases in humans; however, the coupled machines (PET/CT and PET/MRI) are currently only available for small animals.
The major issue with using nuclear medicine imaging in veterinary medicine is not the availability of gamma cameras or the technical expertise required to operate them. Cameras are readily available on the used market, and training of technologists to operate them is not prohibitively complex. The primary issue is the regulations surrounding the acquisition and use of radiopharmaceuticals in animals. All use must be strictly documented and, unlike in human medicine, the veterinary patient generally must remain in the hospital after the study is performed to allow elimination of radionuclides from the body to be essentially complete. This is done to limit exposure of owners to the radionuclides.
A second reason for limited use of nuclear medicine imaging is the physiological nature of the lesions, which results in images of poor spatial resolution even though they are highly sensitive to some disease processes. The special training required for interpretation of these images is provided as part of a veterinary radiology residency program available at only a few centers.
The use of PET imaging in horses has increased markedly since around 2016. PET scanning of the distal limb in horses currently is a highly sensitive but poorly specific imaging modality that allows for 3-dimensional visualization of tissues. It allows for determination of a more precise anatomical location of abnormalities, in addition to their biological activity.
Select academic veterinary institutions, private referral hospitals, and affiliated racetracks have installed equine PET scanners predominately to screen and evaluate racehorses for potentially catastrophic or prodromal lesions. Though popular within the horse racing community, this modality can be used for every equine discipline and breed.
Although the original system that was described for use in horses was a recumbent machine that necessitated the use of general anethesia, the most common examinations today are performed standing and allow for safe, sedated scanning of the distal limbs in equine patients. These proprietary systems are engineered with a breakaway function such that the horse is able to easily exit the system, without injury to personnel, patient, or scanner. With trained technical personnel, PET imaging of the distal limb can be performed in approximately 5 minutes.
The 2 most commonly used nucleotides in PET imaging of horses are 18F-sodium fluoride (18F-NaF) and 18F-fluorodeoxyglucose (18F-FDG) (see NaF PET image).
Courtesy of Dr. Timothy Manzi.
In short, the NaF isotope is helpful for identification of osseous lesions due to its affinity for exposed hydroxyapatite crystals, and the FDG isotope is best used for identification of soft tissue injuries because it is a glucose analog that has high uptake in metabolically active tissues. Once the study is acquired, these native PET images are often coregistered with contemporaneous CT or MRI images, which can be quite time-consuming.
Unlike small animal combined CT/PET machines, the image acquisition in horses is made asynchronously. The areas of uptake (referred to as regions of avidity) can be objectively quantified and provide a more accurate depiction as to the biological activity and suspected clinical relevance of lesions.
The information garnered from these examinations is exponential and ever growing, with considerable promise for bettering the health of equids in the future.
For More Information
Also see pet health content regarding nuclear medicine imaging.